Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Phio Pharmaceuticals Net Change in Short-term Investments 2012-2024 | PHIO

Phio Pharmaceuticals net change in short-term investments from 2012 to 2024. Net change in short-term investments can be defined as the net cash flows from the sale and purchase of investments defined to be short-term, generally with maturities of less than one year from the purchase date.
  
Phio Pharmaceuticals Annual Net Change in Short-term Investments
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
2021 $N/A
2020 $N/A
2019 $N/A
2018 $N/A
2017 $N/A
2016 $6
2015 $-6
2014 $3
2013 $-3
2012 $N/A
2011 $N/A
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.009B $0.000B
Phio Pharmaceuticals Corp is focused on developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi therapeutic platform. The Company's pipeline consists of RXI-762 and RXI-804 which are in clinical stage. Phio Pharmaceuticals Corp, formerly known as RXi Pharmaceuticals Corporation, is based in Marlborough, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $94.617B 35.49
Zoetis (ZTS) United States $69.783B 26.42
Daiichi Sankyo, - (DSNKY) Japan $48.948B 24.90
Takeda Pharmaceutical (TAK) Japan $48.651B 10.77
Sandoz Group AG (SDZNY) Switzerland $19.087B 0.00
Merck (MKKGY) Germany $17.919B 14.83
Summit Therapeutics (SMMT) United States $17.913B 0.00
Shionogi (SGIOY) Japan $14.172B 14.20
United Therapeutics (UTHR) United States $13.667B 12.10
Neurocrine Biosciences (NBIX) United States $10.655B 32.73
IPSEN (IPSEY) France $9.454B 0.00
Orion OYJ (ORINY) Finland $8.841B 23.91
Corcept Therapeutics (CORT) United States $7.622B 57.97
Madrigal Pharmaceuticals (MDGL) United States $7.414B 0.00
Stevanato Group S.p.A (STVN) Italy $6.317B 40.12
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ionis Pharmaceuticals (IONS) United States $4.882B 0.00
Grifols, S.A (GRFS) Spain $4.779B 0.00
Soleno Therapeutics (SLNO) United States $3.736B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.126B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.962B 12.02
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.374B 14.73
Hypermarcas (HYPMY) Brazil $2.350B 15.46
Recursion Pharmaceuticals (RXRX) United States $2.247B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.101B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.851B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.826B 0.00
Indivior (INDV) United States $1.587B 6.73
Guardian Pharmacy Services (GRDN) United States $1.585B 0.00
Evotec AG (EVO) Germany $1.491B 0.00
ARS Pharmaceuticals (SPRY) United States $1.372B 174.62
Dyne Therapeutics (DYN) United States $1.340B 0.00
Ocular Therapeutix (OCUL) United States $1.322B 0.00
Ardelyx (ARDX) United States $1.312B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.126B 45.78
Enliven Therapeutics (ELVN) United States $0.929B 0.00
Harrow (HROW) United States $0.909B 0.00
Collegium Pharmaceutical (COLL) United States $0.867B 4.61
Avadel Pharmaceuticals (AVDL) Ireland $0.859B 0.00
Xencor (XNCR) United States $0.784B 0.00
Cronos Group (CRON) Canada $0.725B 0.00
Xeris Biopharma Holdings (XERS) United States $0.715B 0.00
AleAnna (ANNA) United States $0.690B 0.00
KalVista Pharmaceuticals (KALV) United States $0.685B 0.00
Akebia Therapeutics (AKBA) United States $0.631B 0.00
Organogenesis (ORGO) United States $0.623B 0.00
Bioventus (BVS) United States $0.599B 15.55
Relay Therapeutics (RLAY) United States $0.568B 0.00
Savara (SVRA) United States $0.553B 0.00
USANA Health Sciences (USNA) United States $0.530B 11.37
Regulus Therapeutics (RGLS) United States $0.529B 0.00
Verve Therapeutics (VERV) United States $0.505B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.489B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.455B 0.00
Tourmaline Bio (TRML) United States $0.442B 0.00
Elite Pharmaceuticals (ELTP) United States $0.442B 0.00
Altimmune (ALT) United States $0.404B 0.00
Zevra Therapeutics (ZVRA) United States $0.401B 0.00
Siga Technologies (SIGA) United States $0.394B 6.73
Oruka Therapeutics (ORKA) United States $0.391B 0.00
Heron Therapeutics (HRTX) United States $0.369B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.349B 20.81
CytoDyn (CYDY) United States $0.331B 0.00
Aquestive Therapeutics (AQST) United States $0.291B 0.00
ProKidney (PROK) United States $0.259B 0.00
Avita Medical (RCEL) United States $0.256B 0.00
Nature's Sunshine Products (NATR) United States $0.228B 26.78
Wellgistics Health (WGRX) United States $0.225B 0.00
OmniAb (OABI) United States $0.208B 0.00
Esperion Therapeutics (ESPR) United States $0.198B 24.99
MediWound (MDWD) Israel $0.191B 0.00
Journey Medical (DERM) United States $0.171B 0.00
Larimar Therapeutics (LRMR) United States $0.170B 0.00
Inhibikase Therapeutics (IKT) United States $0.168B 0.00
Korro Bio (KRRO) United States $0.167B 0.00
Nanobiotix S.A (NBTX) France $0.160B 0.00
Aldeyra Therapeutics (ALDX) United States $0.159B 0.00
4D Molecular Therapeutics (FDMT) United States $0.156B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.151B 46.62
Profound Medical (PROF) Canada $0.150B 0.00
Aclaris Therapeutics (ACRS) United States $0.149B 0.00
Nektar Therapeutics (NKTR) United States $0.148B 0.00
Lyell Immunopharma (LYEL) United States $0.140B 0.00
Protara Therapeutics (TARA) United States $0.135B 0.00
Lexeo Therapeutics (LXEO) United States $0.130B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.130B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.116B 0.00
VAXART, INC (VXRT) United States $0.100B 0.00
Champions Oncology (CSBR) United States $0.099B 16.25
OptiNose (OPTN) United States $0.094B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Cardiol Therapeutics (CRDL) Canada $0.091B 0.00
Achieve Life Sciences (ACHV) Canada $0.090B 0.00
Galectin Therapeutics (GALT) United States $0.087B 0.00
ESSA Pharma (EPIX) Canada $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
Unicycive Therapeutics (UNCY) United States $0.078B 0.00
Context Therapeutics (CNTX) United States $0.078B 0.00
Nutriband (NTRB) United States $0.077B 0.00
Telomir Pharmaceuticals (TELO) United States $0.076B 0.00
Cassava Sciences (SAVA) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.067B 0.00
Dominari Holdings (DOMH) United States $0.067B 0.00
Inotiv (NOTV) United States $0.066B 0.00
Metagenomi (MGX) United States $0.065B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Fractyl Health (GUTS) United States $0.062B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Karyopharm Therapeutics (KPTI) United States $0.058B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.053B 0.00
PMV Pharmaceuticals (PMVP) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.043B 0.00
Prelude Therapeutics (PRLD) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
Surrozen (SRZN) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.036B 0.00
FibroGen (FGEN) United States $0.034B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Mannatech (MTEX) United States $0.020B 7.86
DURECT (DRRX) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
BioVie (BIVI) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 8.79
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.10
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
Talphera (TLPH) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00